A multicentre randomised assessment of the DAWN AC computer-assisted oral anticoagulant dosage program

Leon Poller, Michelle Keown, Saied Ibrahim, Gordon Lowe, Marco Moia, Alexander G. Turpie, Christopher Roberts, Anton M H P Van Den Besselaar, Felix J M Van Der Meer, Armando Tripodi, Gualtiero Palareti, Caroline Shiach, Stirling Bryan, Meyer Samama, Burgess Wilson Michael, Anthony Heagerty, Peter MacCallum, David Wright, Jørgen Jespersen

Research output: Contribution to journalArticle

Abstract

Computer-assisted oral anticoagulant dosage is being increasingly used to meet growing demands for oral anticoagulation. The DAWN AC is one of the most widely used computer-dosage programs. Evidence of its value and that of other computer programs has been based previously only on laboratory evidence of "time in target INR range" (TIR) not on clinical safety in practice. A five-year international randomised clinical study of computer assistance with the DAWN AC program compared with manual dosage in 2,631 patients has been performed at 13 centres with established expertise in oral anticoagulation mainly in the EU. Safety assessment have been based on the comparison of bleeding or thrombotic events with DAWN AC compared with manual dosage in a randomised study. Safety of the DAWN AC program has been demonstrated. Clinical events of bleeding and thrombosis were almost identical with the experienced manual dosage group. Therapeutic control improved with DAWN AC to 66.8% from 63.4% TIR.The program failed to provide a dosage recommendation on only 5.7% of occasions. At a group of experienced centres with a special interest in oral anticoagulation, the DAWN AC computer-dosage program proved as safe clinically as manual dosage by experienced medical staff. With DAWN AC, laboratory control was improved, the difference being highly significant. The results should reassure hospitals and community clinics that the DAWN AC program is safe and facilitate greater and longer provision of warfarin treatment where required.

Original languageEnglish
Pages (from-to)487-494
Number of pages8
JournalThrombosis and Haemostasis
Volume101
Issue number3
DOIs
Publication statusPublished - Mar 2009

Fingerprint

Anticoagulants
International Normalized Ratio
Software
Safety
Hemorrhage
Medical Staff
Warfarin
Thrombosis
Therapeutics
Clinical Studies

Keywords

  • Clinical events
  • Computer-dosage
  • Safety DAWN AC
  • Warfarin

ASJC Scopus subject areas

  • Hematology

Cite this

A multicentre randomised assessment of the DAWN AC computer-assisted oral anticoagulant dosage program. / Poller, Leon; Keown, Michelle; Ibrahim, Saied; Lowe, Gordon; Moia, Marco; Turpie, Alexander G.; Roberts, Christopher; Van Den Besselaar, Anton M H P; Van Der Meer, Felix J M; Tripodi, Armando; Palareti, Gualtiero; Shiach, Caroline; Bryan, Stirling; Samama, Meyer; Michael, Burgess Wilson; Heagerty, Anthony; MacCallum, Peter; Wright, David; Jespersen, Jørgen.

In: Thrombosis and Haemostasis, Vol. 101, No. 3, 03.2009, p. 487-494.

Research output: Contribution to journalArticle

Poller, L, Keown, M, Ibrahim, S, Lowe, G, Moia, M, Turpie, AG, Roberts, C, Van Den Besselaar, AMHP, Van Der Meer, FJM, Tripodi, A, Palareti, G, Shiach, C, Bryan, S, Samama, M, Michael, BW, Heagerty, A, MacCallum, P, Wright, D & Jespersen, J 2009, 'A multicentre randomised assessment of the DAWN AC computer-assisted oral anticoagulant dosage program', Thrombosis and Haemostasis, vol. 101, no. 3, pp. 487-494. https://doi.org/10.1160/TH08-10-0664
Poller, Leon ; Keown, Michelle ; Ibrahim, Saied ; Lowe, Gordon ; Moia, Marco ; Turpie, Alexander G. ; Roberts, Christopher ; Van Den Besselaar, Anton M H P ; Van Der Meer, Felix J M ; Tripodi, Armando ; Palareti, Gualtiero ; Shiach, Caroline ; Bryan, Stirling ; Samama, Meyer ; Michael, Burgess Wilson ; Heagerty, Anthony ; MacCallum, Peter ; Wright, David ; Jespersen, Jørgen. / A multicentre randomised assessment of the DAWN AC computer-assisted oral anticoagulant dosage program. In: Thrombosis and Haemostasis. 2009 ; Vol. 101, No. 3. pp. 487-494.
@article{4e8176d40902488588c83b88133b4421,
title = "A multicentre randomised assessment of the DAWN AC computer-assisted oral anticoagulant dosage program",
abstract = "Computer-assisted oral anticoagulant dosage is being increasingly used to meet growing demands for oral anticoagulation. The DAWN AC is one of the most widely used computer-dosage programs. Evidence of its value and that of other computer programs has been based previously only on laboratory evidence of {"}time in target INR range{"} (TIR) not on clinical safety in practice. A five-year international randomised clinical study of computer assistance with the DAWN AC program compared with manual dosage in 2,631 patients has been performed at 13 centres with established expertise in oral anticoagulation mainly in the EU. Safety assessment have been based on the comparison of bleeding or thrombotic events with DAWN AC compared with manual dosage in a randomised study. Safety of the DAWN AC program has been demonstrated. Clinical events of bleeding and thrombosis were almost identical with the experienced manual dosage group. Therapeutic control improved with DAWN AC to 66.8{\%} from 63.4{\%} TIR.The program failed to provide a dosage recommendation on only 5.7{\%} of occasions. At a group of experienced centres with a special interest in oral anticoagulation, the DAWN AC computer-dosage program proved as safe clinically as manual dosage by experienced medical staff. With DAWN AC, laboratory control was improved, the difference being highly significant. The results should reassure hospitals and community clinics that the DAWN AC program is safe and facilitate greater and longer provision of warfarin treatment where required.",
keywords = "Clinical events, Computer-dosage, Safety DAWN AC, Warfarin",
author = "Leon Poller and Michelle Keown and Saied Ibrahim and Gordon Lowe and Marco Moia and Turpie, {Alexander G.} and Christopher Roberts and {Van Den Besselaar}, {Anton M H P} and {Van Der Meer}, {Felix J M} and Armando Tripodi and Gualtiero Palareti and Caroline Shiach and Stirling Bryan and Meyer Samama and Michael, {Burgess Wilson} and Anthony Heagerty and Peter MacCallum and David Wright and J{\o}rgen Jespersen",
year = "2009",
month = "3",
doi = "10.1160/TH08-10-0664",
language = "English",
volume = "101",
pages = "487--494",
journal = "Thrombosis and Haemostasis",
issn = "0340-6245",
publisher = "Schattauer GmbH",
number = "3",

}

TY - JOUR

T1 - A multicentre randomised assessment of the DAWN AC computer-assisted oral anticoagulant dosage program

AU - Poller, Leon

AU - Keown, Michelle

AU - Ibrahim, Saied

AU - Lowe, Gordon

AU - Moia, Marco

AU - Turpie, Alexander G.

AU - Roberts, Christopher

AU - Van Den Besselaar, Anton M H P

AU - Van Der Meer, Felix J M

AU - Tripodi, Armando

AU - Palareti, Gualtiero

AU - Shiach, Caroline

AU - Bryan, Stirling

AU - Samama, Meyer

AU - Michael, Burgess Wilson

AU - Heagerty, Anthony

AU - MacCallum, Peter

AU - Wright, David

AU - Jespersen, Jørgen

PY - 2009/3

Y1 - 2009/3

N2 - Computer-assisted oral anticoagulant dosage is being increasingly used to meet growing demands for oral anticoagulation. The DAWN AC is one of the most widely used computer-dosage programs. Evidence of its value and that of other computer programs has been based previously only on laboratory evidence of "time in target INR range" (TIR) not on clinical safety in practice. A five-year international randomised clinical study of computer assistance with the DAWN AC program compared with manual dosage in 2,631 patients has been performed at 13 centres with established expertise in oral anticoagulation mainly in the EU. Safety assessment have been based on the comparison of bleeding or thrombotic events with DAWN AC compared with manual dosage in a randomised study. Safety of the DAWN AC program has been demonstrated. Clinical events of bleeding and thrombosis were almost identical with the experienced manual dosage group. Therapeutic control improved with DAWN AC to 66.8% from 63.4% TIR.The program failed to provide a dosage recommendation on only 5.7% of occasions. At a group of experienced centres with a special interest in oral anticoagulation, the DAWN AC computer-dosage program proved as safe clinically as manual dosage by experienced medical staff. With DAWN AC, laboratory control was improved, the difference being highly significant. The results should reassure hospitals and community clinics that the DAWN AC program is safe and facilitate greater and longer provision of warfarin treatment where required.

AB - Computer-assisted oral anticoagulant dosage is being increasingly used to meet growing demands for oral anticoagulation. The DAWN AC is one of the most widely used computer-dosage programs. Evidence of its value and that of other computer programs has been based previously only on laboratory evidence of "time in target INR range" (TIR) not on clinical safety in practice. A five-year international randomised clinical study of computer assistance with the DAWN AC program compared with manual dosage in 2,631 patients has been performed at 13 centres with established expertise in oral anticoagulation mainly in the EU. Safety assessment have been based on the comparison of bleeding or thrombotic events with DAWN AC compared with manual dosage in a randomised study. Safety of the DAWN AC program has been demonstrated. Clinical events of bleeding and thrombosis were almost identical with the experienced manual dosage group. Therapeutic control improved with DAWN AC to 66.8% from 63.4% TIR.The program failed to provide a dosage recommendation on only 5.7% of occasions. At a group of experienced centres with a special interest in oral anticoagulation, the DAWN AC computer-dosage program proved as safe clinically as manual dosage by experienced medical staff. With DAWN AC, laboratory control was improved, the difference being highly significant. The results should reassure hospitals and community clinics that the DAWN AC program is safe and facilitate greater and longer provision of warfarin treatment where required.

KW - Clinical events

KW - Computer-dosage

KW - Safety DAWN AC

KW - Warfarin

UR - http://www.scopus.com/inward/record.url?scp=62549128661&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62549128661&partnerID=8YFLogxK

U2 - 10.1160/TH08-10-0664

DO - 10.1160/TH08-10-0664

M3 - Article

C2 - 19277410

AN - SCOPUS:62549128661

VL - 101

SP - 487

EP - 494

JO - Thrombosis and Haemostasis

JF - Thrombosis and Haemostasis

SN - 0340-6245

IS - 3

ER -